These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 23466044

  • 1. Practice patterns among pediatric urologists in the use of Deflux® for vesicoureteral reflux: a survey.
    Cambareri GM, Hanna MK, Stock JA.
    J Pediatr Urol; 2013 Dec; 9(6 Pt A):955-61. PubMed ID: 23466044
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of dextranomer/hyaluronic acid based bulking agents in the treatment of vesicoureteral reflux in children: Deflux versus Vurdex.
    Pogorelić Z, Gudelj K, Budimir D, Todorić J, Jukić M, Furlan D, Košuljandić Đ, Saraga M.
    Can J Urol; 2016 Jun; 23(3):8312-7. PubMed ID: 27347628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and safety in children with vesicoureteral reflux of a single injection of two different bulking agents--polydimethylsiloxane (Macroplastique) or dextranomer/hyaluronic acid copolymer (Deflux): a short-term prospective comparative study.
    Kim SO, Shin BS, Hwang IS, Hwang EC, Oh KJ, Jung SI, Kang TW, Kwon D, Park K, Ryu SB.
    Urol Int; 2011 Jun; 87(3):299-303. PubMed ID: 21934268
    [Abstract] [Full Text] [Related]

  • 11. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
    Kirsch AJ, Perez-Brayfield MR, Scherz HC.
    J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of Bladder Ultrasound in Prediction of Resolution of Vesicoureteral Reflux After Endoscopic Subureteral Hyaluronic Acid/Dextranomer (Deflux) Injection.
    Aboutaleb H, Eldib DB, Farahat Y, Abouelgreed TA, Zanaty F.
    Urology; 2022 Jul; 165():299-304. PubMed ID: 35065987
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is there a learning curve for subureteric injection of dextranomer/hyaluronic acid in the treatment of vesicoureteral reflux?
    Bennett SD, Foot LM, Abel EJ, Snow BW, Cartwright PC, Devries CR, Wallis MC.
    J Pediatr Urol; 2010 Apr; 6(2):122-4. PubMed ID: 19740702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Effectiveness of Deflux® Treatment for Vesicoureteral Reflux Following Pediatric Renal Transplantation: A Single-Institution Challenging Experience.
    Obata S, Nagata K, Suematsu S, Nishiyama K, Okabe Y, Kondo T, Maniwa J, Fukuta A, Kawakubo N, Yanagi Y, Miyata J, Matsuura T, Ohga S, Nakamura M, Tajiri T.
    J Pediatr Surg; 2024 Apr; 59(4):616-620. PubMed ID: 38161090
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.
    Benoit RM, Peele PB, Docimo SG.
    J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.